￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Aficamten-MYQORZO manual Chinese introduction

2026-02-01 22:25:32

Check Details
The specific efficacy and role of larotrectinib/vitaikai in the treatment of cancer

2026-02-01 22:25:32

Check Details
STOMP trial analysis reveals the immunomodulatory effects of selinezo/silvio in RRMM

2026-02-01 22:25:32

Check Details
Detailed explanation of the efficacy and role of Vigabatrin/vigabatrin in treating epilepsy

2026-02-01 22:25:32

Check Details
How Mobocertinib inhibits EGFR exon 20 to treat disease

2026-02-01 22:25:32

Check Details
Is mirikizumab available in the country? What is the market situation?

2026-02-01 22:25:32

Check Details
What are the combination regimens of selumetinib/coceyu?

2026-02-01 22:25:32

Check Details
Aficamten-MYQORZO’s functions and effects

2026-02-01 22:25:32

Check Details
What are the medical insurance reimbursement conditions for lorlatinib/lorlatinib?

2026-02-01 22:25:32

Check Details
Which is better, cabozantinib tablets or capsules?

2026-02-01 22:25:32

Check Details
What are the side effects of Platinib/Pujihua? What issues should patients pay attention to

2026-02-01 22:25:32

Check Details
What is the difference between capmatinib/touradida and savotinib?

2026-02-01 22:25:32

Check Details
Category
相关知识